Cell therapy startup Myeloid narrows focus as staff shrinksnews2025-04-15T01:38:14+00:00April 15th, 2025|Endpoints News|
Verve unveils early data from second attempt at heart disease gene editingnews2025-04-14T11:00:35+00:00April 14th, 2025|Endpoints News|
Cell and gene therapy CDMO AmplifyBio shuts down over ‘scarcity’ of fundingnews2025-04-07T10:26:49+00:00April 7th, 2025|Endpoints News|
Exclusive: Neurona bags $102M to treat epilepsy with cell therapynews2025-04-03T10:00:15+00:00April 3rd, 2025|Endpoints News|
Biopharma execs rethink Trump impact after FDA cutsnews2025-04-02T19:47:10+00:00April 2nd, 2025|Endpoints News|
Atsena raises $150M to target rare form of blindness with gene therapynews2025-04-02T11:30:59+00:00April 2nd, 2025|Endpoints News|
New CDMO emerges, acquires cell and gene manufacturer Landmark Bionews2025-04-02T09:00:38+00:00April 2nd, 2025|Endpoints News|
DC court sides with HHS in Vertex’s fertility program fightnews2025-03-31T19:57:10+00:00March 31st, 2025|Endpoints News|
Heart gene therapy company Tenaya to lay off 30% to 40% of staffnews2025-03-31T19:45:52+00:00March 31st, 2025|Endpoints News|
